Logo image of PTVE

PACTIV EVERGREEN INC (PTVE) Stock Fundamental Analysis

NASDAQ:PTVE - US69526K1051 - Common Stock

18.01 USD
+0.05 (+0.28%)
Last: 3/31/2025, 8:00:02 PM
18.02 USD
+0.01 (+0.06%)
After Hours: 3/31/2025, 8:00:02 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PTVE. PTVE was compared to 22 industry peers in the Containers & Packaging industry. PTVE has a medium profitability rating, but doesn't score so well on its financial health evaluation. PTVE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year PTVE was profitable.
In the past year PTVE had a positive cash flow from operations.
In multiple years PTVE reported negative net income over the last 5 years.
In the past 5 years PTVE always reported a positive cash flow from operatings.
PTVE Yearly Net Income VS EBIT VS OCF VS FCFPTVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

PTVE's Return On Assets of -2.37% is on the low side compared to the rest of the industry. PTVE is outperformed by 83.33% of its industry peers.
PTVE has a worse Return On Equity (-12.58%) than 79.17% of its industry peers.
The Return On Invested Capital of PTVE (7.90%) is better than 66.67% of its industry peers.
PTVE had an Average Return On Invested Capital over the past 3 years of 5.29%. This is below the industry average of 7.56%.
The 3 year average ROIC (5.29%) for PTVE is below the current ROIC(7.90%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.37%
ROE -12.58%
ROIC 7.9%
ROA(3y)-0.52%
ROA(5y)-0.32%
ROE(3y)-2.95%
ROE(5y)-1.91%
ROIC(3y)5.29%
ROIC(5y)4.02%
PTVE Yearly ROA, ROE, ROICPTVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

1.3 Margins

PTVE has a Operating Margin (9.56%) which is in line with its industry peers.
In the last couple of years the Operating Margin of PTVE has grown nicely.
PTVE has a worse Gross Margin (19.09%) than 70.83% of its industry peers.
PTVE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.56%
PM (TTM) N/A
GM 19.09%
OM growth 3Y63.34%
OM growth 5Y5.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.8%
GM growth 5Y3.17%
PTVE Yearly Profit, Operating, Gross MarginsPTVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PTVE is still creating some value.
PTVE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PTVE has been increased compared to 5 years ago.
The debt/assets ratio for PTVE is higher compared to a year ago.
PTVE Yearly Shares OutstandingPTVE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
PTVE Yearly Total Debt VS Total AssetsPTVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

PTVE has an Altman-Z score of 1.78. This is a bad value and indicates that PTVE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of PTVE (1.78) is worse than 62.50% of its industry peers.
PTVE has a debt to FCF ratio of 21.01. This is a negative value and a sign of low solvency as PTVE would need 21.01 years to pay back of all of its debts.
PTVE's Debt to FCF ratio of 21.01 is in line compared to the rest of the industry. PTVE outperforms 41.67% of its industry peers.
PTVE has a Debt/Equity ratio of 2.90. This is a high value indicating a heavy dependency on external financing.
PTVE has a Debt to Equity ratio of 2.90. This is in the lower half of the industry: PTVE underperforms 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.9
Debt/FCF 21.01
Altman-Z 1.78
ROIC/WACC1.12
WACC7.06%
PTVE Yearly LT Debt VS Equity VS FCFPTVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

PTVE has a Current Ratio of 1.54. This is a normal value and indicates that PTVE is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of PTVE (1.54) is better than 70.83% of its industry peers.
PTVE has a Quick Ratio of 1.54. This is a bad value and indicates that PTVE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.74, PTVE perfoms like the industry average, outperforming 45.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 0.74
PTVE Yearly Current Assets VS Current LiabilitesPTVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 855.56% over the past year.
The Earnings Per Share has been growing by 34.94% on average over the past years. This is a very strong growth
PTVE shows a decrease in Revenue. In the last year, the revenue decreased by -6.57%.
PTVE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.17% yearly.
EPS 1Y (TTM)855.56%
EPS 3Y34.94%
EPS 5YN/A
EPS Q2Q%-42.42%
Revenue 1Y (TTM)-6.57%
Revenue growth 3Y-1.8%
Revenue growth 5Y-0.17%
Sales Q2Q%15.46%

3.2 Future

Based on estimates for the next years, PTVE will show a very strong growth in Earnings Per Share. The EPS will grow by 30.10% on average per year.
The Revenue is expected to grow by 2.22% on average over the next years.
EPS Next Y49.38%
EPS Next 2Y30.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.61%
Revenue Next 2Y2.22%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PTVE Yearly Revenue VS EstimatesPTVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B 10B
PTVE Yearly EPS VS EstimatesPTVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.94, which indicates a rather expensive current valuation of PTVE.
PTVE's Price/Earnings ratio is a bit more expensive when compared to the industry. PTVE is more expensive than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.08, PTVE is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 14.02, the valuation of PTVE can be described as correct.
PTVE's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of PTVE to the average of the S&P500 Index (22.67), we can say PTVE is valued slightly cheaper.
Industry RankSector Rank
PE 20.94
Fwd PE 14.02
PTVE Price Earnings VS Forward Price EarningsPTVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

62.50% of the companies in the same industry are more expensive than PTVE, based on the Enterprise Value to EBITDA ratio.
PTVE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 19.96
EV/EBITDA 8.18
PTVE Per share dataPTVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PTVE's earnings are expected to grow with 30.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y30.1%
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

PTVE has a Yearly Dividend Yield of 2.22%.
Compared to an average industry Dividend Yield of 3.14, PTVE has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, PTVE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.22%

5.2 History

PTVE has been paying a dividend for less than 5 years, so it still needs to build a track record.
PTVE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
PTVE Yearly Dividends per sharePTVE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0 0 0 0 0

5.3 Sustainability

PTVE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-51.8%
EPS Next 2Y30.1%
EPS Next 3YN/A
PTVE Yearly Income VS Free CF VS DividendPTVE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

PACTIV EVERGREEN INC

NASDAQ:PTVE (3/31/2025, 8:00:02 PM)

After market: 18.02 +0.01 (+0.06%)

18.01

+0.05 (+0.28%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)02-25 2025-02-25/bmo
Earnings (Next)04-30 2025-04-30/amc
Inst Owners22.82%
Inst Owner Change-97.35%
Ins Owners0.86%
Ins Owner Change-38207.8%
Market Cap3.25B
Analysts50
Price Target18.19 (1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.22%
Yearly Dividend0.4
Dividend Growth(5Y)N/A
DP-51.8%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.05%
Min EPS beat(2)-49.15%
Max EPS beat(2)-2.95%
EPS beat(4)1
Avg EPS beat(4)-5.04%
Min EPS beat(4)-49.15%
Max EPS beat(4)65.09%
EPS beat(8)3
Avg EPS beat(8)-130.46%
EPS beat(12)7
Avg EPS beat(12)-8.25%
EPS beat(16)8
Avg EPS beat(16)-14.91%
Revenue beat(2)1
Avg Revenue beat(2)3.89%
Min Revenue beat(2)-4.85%
Max Revenue beat(2)12.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.04%
Min Revenue beat(4)-4.85%
Max Revenue beat(4)12.63%
Revenue beat(8)1
Avg Revenue beat(8)-2.47%
Revenue beat(12)3
Avg Revenue beat(12)-1.29%
Revenue beat(16)7
Avg Revenue beat(16)0.34%
PT rev (1m)0%
PT rev (3m)1.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.11%
EPS NY rev (1m)-1.95%
EPS NY rev (3m)-1.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.19%
Valuation
Industry RankSector Rank
PE 20.94
Fwd PE 14.02
P/S 0.63
P/FCF 19.96
P/OCF 8.24
P/B 2.94
P/tB N/A
EV/EBITDA 8.18
EPS(TTM)0.86
EY4.78%
EPS(NY)1.28
Fwd EY7.13%
FCF(TTM)0.9
FCFY5.01%
OCF(TTM)2.19
OCFY12.14%
SpS28.5
BVpS6.12
TBVpS-9.11
PEG (NY)0.42
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.37%
ROE -12.58%
ROCE 10.01%
ROIC 7.9%
ROICexc 8.15%
ROICexgc 19.23%
OM 9.56%
PM (TTM) N/A
GM 19.09%
FCFM 3.17%
ROA(3y)-0.52%
ROA(5y)-0.32%
ROE(3y)-2.95%
ROE(5y)-1.91%
ROIC(3y)5.29%
ROIC(5y)4.02%
ROICexc(3y)5.55%
ROICexc(5y)4.23%
ROICexgc(3y)12.09%
ROICexgc(5y)9.06%
ROCE(3y)6.69%
ROCE(5y)5.09%
ROICexcg growth 3Y84.3%
ROICexcg growth 5Y35.68%
ROICexc growth 3Y73.17%
ROICexc growth 5Y22.28%
OM growth 3Y63.34%
OM growth 5Y5.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.8%
GM growth 5Y3.17%
F-Score6
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 2.9
Debt/FCF 21.01
Debt/EBITDA 4.01
Cap/Depr 75.82%
Cap/Sales 4.51%
Interest Coverage 2.21
Cash Conversion 49.5%
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 0.74
Altman-Z 1.78
F-Score6
WACC7.06%
ROIC/WACC1.12
Cap/Depr(3y)66.47%
Cap/Depr(5y)73.84%
Cap/Sales(3y)4.61%
Cap/Sales(5y)5.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)855.56%
EPS 3Y34.94%
EPS 5YN/A
EPS Q2Q%-42.42%
EPS Next Y49.38%
EPS Next 2Y30.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.57%
Revenue growth 3Y-1.8%
Revenue growth 5Y-0.17%
Sales Q2Q%15.46%
Revenue Next Year1.61%
Revenue Next 2Y2.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y151.02%
EBIT growth 3Y60.39%
EBIT growth 5Y5.2%
EBIT Next Year75.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.54%
FCF growth 3YN/A
FCF growth 5Y-9.4%
OCF growth 1Y-26.03%
OCF growth 3Y14.81%
OCF growth 5Y-15.11%